Mul­ti­ple scle­ro­sis (MS): How the train­ing with Pix­for­mance can improve the qual­i­ty of life of peo­ple with MS

Mul­ti­ple scle­ro­sis (MS): How the train­ing with Pix­for­mance can improve the qual­i­ty of life of peo­ple with MS

Mul­ti­ple scle­ro­sis (MS) is one of the most com­mon neu­ro­log­i­cal con­di­tions of young adults in the US. In this arti­cle, we intro­duce a recent qual­i­ta­tive study that test­ed the effec­tive­ness of phys­i­cal ther­a­py based on the Pix­for­mance sta­tion and its poten­tial for improv­ing the lives of peo­ple liv­ing with MS.

At age 28, she notices the symp­toms for the first time. Short­ly before grad­u­at­ing from col­lege, Lisa wakes up one day with a feel­ing of numb­ness in her legs. Her fam­i­ly physi­cian refers her to a col­league, who soon refers her to a neu­rol­o­gist. After a num­ber of tests, she is diag­nosed with the neu­ro­log­i­cal dis­ease MS that affects the ner­vous sys­tem.

This is often how the sto­ry of peo­ple liv­ing with the chron­i­cal­ly inflam­ma­to­ry dis­ease MS starts. Yet, the con­di­tion also makes itself known through oth­er symp­toms such as impaired vision, vestibu­lar dis­or­der, an inabil­i­ty to focus as well as fatigue. Although all of these symp­toms can indi­cate MS, they don’t nec­es­sar­i­ly have to, which is why it is hard to diag­nose the dis­ease.

 

multiple sclerosis pixformanceMul­ti­ple scle­ro­sis: a few facts

World­wide, an esti­mat­ed num­ber of 2.5 mil­lion peo­ple live with the diag­no­sis MS. Women are three times more like­ly to be affect­ed by MS. The ill­ness which is also known as “the dis­ease with many faces” due to its unspe­cif­ic symp­toms is espe­cial­ly com­mon in west­ern indus­tri­al­ized coun­tries. That’s why researchers assume that envi­ron­men­tal as well as genet­ic influ­ences trig­ger the con­di­tion; yet, the spe­cif­ic cause is still unknown.

Accord­ing to the Mul­ti­ple Scle­ro­sis Foun­da­tion, about 400,000 peo­ple in the US have MS. Typ­i­cal­ly, MS is found in peo­ple who are between 20 and 40 years old, which is why the ill­ness is con­sid­ered one of the most com­mon neu­ro­log­i­cal dis­eases of young adults.

 

Pro­gres­sion and treat­ment

MS often­times evolves unpre­dictably because the dis­ease pro­gress­es in episodes before, in 40 % of cas­es, flare-ups start occur­ring more fre­quent­ly (sec­ondary pro­gres­sive MS). This means that symp­toms appear to be unre­lat­ed at first, but, as they start occur­ring more fre­quent­ly, the con­di­tion can tran­si­tion into the chron­i­cal­ly pro­gres­sive form.

That’s why ther­a­py is essen­tial for peo­ple with MS. Although there is no known cure yet, treat­ment can help peo­ple to man­age symp­toms. Espe­cial­ly new ther­a­peu­tic mea­sures, new forms of med­ica­tion and tech­no­log­i­cal inno­va­tions can improve the qual­i­ty of life of peo­ple who have MS.

 

Phys­i­cal Ther­a­py with Pix­for­mance

In a 16-week-long sin­gle-case-study, the Fre­se­nius Uni­ver­si­ty of Applied Sci­ences (Frank­furt) test­ed if the train­ing with Pix­for­mance improved the abil­i­ty to walk of a patient with MS. The par­tic­i­pant, who was train­ing with the Pix­for­mance sta­tion through­out the study, clear­ly improved her bal­ance abil­i­ty.

The researchers point­ed out that the train­ing with Pix­for­mance also had a pos­i­tive impact on the participant’s qual­i­ty of life and men­tal health. Even though the find­ings were made in a qual­i­ta­tive study, the researchers stressed that the results and insights could also apply to “sim­i­lar peo­ple and groups”.

Final­ly, the researchers indi­cat­ed that “reg­u­lar exer­cise, also with short recov­ery breaks, can have a pos­i­tive impact” on peo­ple with MS. They also stressed the chances of a long-term pos­i­tive impact, which the Pix­for­mance sta­tion presents, as “the ther­a­peu­tic effects can be main­tained over longer peri­ods of time and can even be accel­er­at­ed”.

multiple sclerosis pixformance

Con­clu­sion

The train­ing with the Pix­for­mance sta­tion can improve the well-being and qual­i­ty of life of peo­ple with MS.